Spectaire Launches into European Trucking Market with Signed Distribution Agreement
January 11, 2024
Partnership with MLab and Mosolf Set to Revolutionize Emissions Monitoring to 6.5 million Potential Commercial Trucks in the EU WATERTOWN, Mass. -- Spectaire Holdings Inc. (NASDAQ: SPEC), an innovator in air quality monitoring and emissions reduction technology, today announced a strategic distribution agreement with MLab, alongside their service and distribution partner Mosolf, to bring the [...]
Hiden Analytical Ltd Introduces Performance Enhanced QGA 2.0 Gas Analyser
January 11, 2024
Hiden Analytical Ltd proudly announces the launch of the QGA 2.0, a significant evolution in gas analysis technology. This next-generation analyser outperforms its predecessor with notable enhancements in speed, precision, and functionality, setting new standards in gas analysis. Key performance enhancements include: Increased Speed: The QGA 2.0 performs 1000 measurements per second, offering rapid analysis. Advanced Precision: Exceptional [...]
Boehringer Ingelheim signs a two-year agreement with Qlucore
January 11, 2024
Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK. As a leading pharmaceutical company engaged in research and development across multiple locations worldwide and a previous customer of Qlucore, the license enables global utilization of Qlucore Omics Explorer software. Qlucore Omics Explorer is [...]
RIGAKU ANALYZES SAMPLES COLLECTED BY NASA’S OSIRIS-REX
January 11, 2024
Thermal analysis produces valuable insights about the evolution of Bennu, a near-earth asteroid TOKYO, JAPAN -- Rigaku, a global solution partner in X-ray-analysis and thermal analysis, is pleased to announce that it has conducted analysis of sand grains from Bennu, a near-earth asteroid, using a thermogravimetry-differential-thermal-analysis/gas-chromatography—mass-spectrometry (TG-DTA/GC-MS) system. The sand grains from Bennu were part of a [...]
January 11, 2024
Menlo Park, CA – Accelerated Technology Laboratories (ATL) and Quality Systems International (QSI) today announce a merger between the two businesses, which was facilitated by the financial backing of STG. The new entity will be re-branded as Confience, drawing on root words “confido,” or trust, a core value of the company, and “science,” a core [...]
January 11, 2024
FOSTER CITY – -Illumina® Ventures Labs, an early-stage company creation and investment engine with fully equipped genomics labs based in Foster City, CA and Cambridge, UK, is now operational and finalizing agreements with several startup companies. Illumina Ventures Labs is part of Illumina Ventures, the premier genomics and precision health venture firm supporting early-stage companies transforming [...]
January 11, 2024
Integrated and Intuitive workflows designed to generate actionable insights into somatic cancers and hereditary diseases MOUNTAIN VIEW, Calif. & SAN DIEGO -- DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Intelliseq, a genome informatics company and innovative provider of next-generation sequencing (NGS) analysis solutions, today announced a partnership to simplify and accelerate variant [...]
January 11, 2024
Sapio’s unified LIMS and ELN platform for research and clinical informatics has been validated for use in labs that follow "good practice" (GMP, GLP, and GCP) quality guidelines and regulations BALTIMORE -- Sapio Sciences, the science-aware™ lab informatics platform, today announced that its unified platform for research and clinical informatics has been validated to comply with [...]
January 11, 2024
PARIS, France – Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its [...]
January 11, 2024
The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more. LIMERICK, Pa.— For over 60 years, Rockland has been providing antibodies, assays, and supporting reagents to accurately reflect the quality of biopharmaceutical products [...]

